Academic-industry collaboration develops point-of-case COVID-19 diagnostic (IMAGE)
Caption
The Wyss Institute collaborates with GBS Inc., a subsidiary of The iQ Group Global, to combine its electrochemical eRapid sensing technology with the GBS's transistor technology in developing a multiplexed COVID-19 biomarker diagnostic for point-of-care applications.
Credit
Wyss Institute at Harvard University
Usage Restrictions
None
License
Licensed content